- CureToday.com
- OncLive.com
- TargetedOnc.com
- Contact
- Terms and Conditions
- Privacy
- Do Not Sell My Personal Information
© 2021 MJH Life Sciences™ and Cancer Network. All rights reserved.
Sara M. Tolaney, MD, MPH | Authors
Articles
Abemaciclib Shows Activity for HR-Positive Breast Cancer Brain Mets
June 30, 2017
This video examines an early trial studying abemaciclib for the treatment of brain metastases in patients with hormone receptor–positive, HER2-negative breast cancer.
Long-Term Data Confirm TH Benefit in Early HER2-Positive Breast Cancer
June 30, 2017
This video highlights 7-year follow-up data from the APT trial, which studied adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer.
Possible to Reduce Treatment Burden in HER2-Positive Breast Cancer?
March 01, 2017
This video examines the idea of using clinical features (age, tumor size) to reduce treatment burden in patients with HER2-positive breast cancer.
Adjuvant Chemotherapy Options in HER2-Positive Breast Cancer
March 01, 2017
This video examines chemotherapy options for HER2-positive breast cancer in the adjuvant setting, and what evidence there is for alternatives to an anthracycline backbone.